Clinical and pathological disappearance of peritoneal dissemination in a patient with advanced gastric cancer receiving chemotherapy with S-1 and low-dose cisplatin

被引:4
|
作者
Akatsu Y. [1 ]
Saikawa Y. [1 ]
Kubota T. [1 ]
Yoshida M. [1 ]
Furukawa T. [1 ]
Otani Y. [1 ]
Kumai K. [2 ]
Kitajima M. [1 ]
机构
[1] Department of Surgery, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582
[2] Ctr. for Diagn./Therapeut. Endoscopy, Keio University School of Medicine, Tokyo
关键词
Cisplatin; Gastric cancer; Peritoneal dissemination; S-1;
D O I
10.1007/s10120-004-0281-8
中图分类号
学科分类号
摘要
A 54-year-old woman with severe abdominal distention suffered from massive ascites. Cytological examination revealed adenocareinoma cells, leading to a diagnosis of peritonitis carcinomatosa. Gastrointestinal fiberseopy (GIF) resulted in a histological diagnosis of type 4 advanced gastric cancer with signet-ring cell carcinoma. The clinical diagnosis was confirmed to be cT3(SE)cN1cM0cH0cP1, cStage IV gastric cancer, type 4, according to the Japanese classification of gastric carcinoma. The patient was treated with S-1 and low-dose cisplatin (CDDP) in order to alleviate the critical state of the disease. After the third cycle of the regimen, the clinical response of P1 was classified as a partial response (PR) according to the World Health Organization (WHO) criteria. The patient's appetite loss and abdominal discomfort were markedly alleviated. The patient experienced grade 2 leukocytopenia throughout the regimen. Surgery was performed. Ascites and peritoneal disseminated lesions were not observed, and cytological examination of the peritoneal washes was negative. Total gastrectomy with D1 lymph node dissection was performed, and the surgical diagnosis was sT3(SE)sN0sM0sH0sP0; sStage II Microscopically, viable cancer cells were found to be scattered throughout the subserosal-serosal layers in the resected stomach. All of the samples from lesions that were potentially cancers involving peritoneal dissemination were diagnosed as fibrous scar tissues without any viable cancer cells. The patient is alive without recurrence at 10 months after surgery and 14 months after the initial chemotherapy. Thus, systemic chemotherapy with S-1/low-dose CDDP achieved desirable control of peritoneal disseminated cells, as assessed microscopically, suggesting that the regimen may be an effective strategy for the treatment of advanced gastric cancer with peritonitis carcinomatosa.
引用
收藏
页码:128 / 133
页数:5
相关论文
共 50 条
  • [1] Combination chemotherapy of S-1 and low-dose cisplatin for advanced gastric cancer
    Shunichi Tsujitani
    Kenji Fukuda
    Nobuaki Kaibara
    Gastric Cancer, 2003, 6 (Suppl 1) : 50 - 57
  • [2] Complete response of highly advanced gastric cancer with peritoneal dissemination after new combined chemotherapy of S-1 and low-dose cisplatin: Report of a case
    Iwahashi, M
    Nakamori, M
    Tani, M
    Yamaue, H
    Sakaguchi, S
    Nakamura, M
    Ueda, K
    Ichiro, M
    Nishino, E
    Tanimura, H
    ONCOLOGY, 2001, 61 (01) : 16 - 22
  • [3] A pilot study of combination chemotherapy with S-1 and low-dose cisplatin for highly advanced gastric cancer
    Takahashi, T
    Saikawa, Y
    Yoshida, M
    Kitagawa, Y
    Otani, Y
    Kubota, T
    Kumai, K
    Kitajima, M
    ANTICANCER RESEARCH, 2006, 26 (2B) : 1631 - 1635
  • [4] High efficacy of combination chemotherapy with S-1 and low-dose docetaxel for the treatment of highly advanced gastric cancer with peritoneal dissemination: A case report
    Zhu, Lucheng
    Luo, Wenhua
    Wei, Juan
    Zou, Changlin
    ONCOLOGY LETTERS, 2013, 5 (05) : 1509 - 1512
  • [5] Alternating Treatment with S-1 Plus Low-Dose Cisplatin and S-1 Alone for Advanced Gastric Cancer
    Kazuhito Mita
    Hideto Ito
    Masato Fukumoto
    Ryo Murabayashi
    Kazuya Koizumi
    Takashi Hayashi
    Hiroyuki Kikuchi
    Tadashi Kagaya
    Journal of Gastrointestinal Surgery, 2011, 15 : 791 - 796
  • [6] Alternating Treatment with S-1 Plus Low-Dose Cisplatin and S-1 Alone for Advanced Gastric Cancer
    Mita, Kazuhito
    Ito, Hideto
    Fukumoto, Masato
    Murabayashi, Ryo
    Koizumi, Kazuya
    Hayashi, Takashi
    Kikuchi, Hiroyuki
    Kagaya, Tadashi
    JOURNAL OF GASTROINTESTINAL SURGERY, 2011, 15 (05) : 791 - 796
  • [7] Histological complete response in a case of advanced gastric cancer treated by chemotherapy with S-1 plus low-dose cisplatin and radiation
    Takahashi, T
    Saikawa, Y
    Kubota, T
    Akiba, Y
    Shigematsu, N
    Yoshida, M
    Otani, Y
    Kumai, K
    Hibi, T
    Kitajima, M
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (11) : 584 - 588
  • [8] Phase II study of chemoradiotherapy with S-1 and low-dose cisplatin for inoperable advanced gastric cancer
    Saikawa, Yoshir
    Kubota, Tetsuro
    Kumagai, Kosm
    Nakamura, Rieko
    Kumai, Koichiro
    Shigematsu, Naoyuki
    Kubo, Atsushi
    Kitajima, Masaki
    Kitagawa, Yuko
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (01): : 173 - 179
  • [9] Induction Chemotherapy with S-1 Plus Cisplatin Followed by Surgery for Treatment of Gastric Cancer with Peritoneal Dissemination
    Okabe, Hiroshi
    Ueda, Shugo
    Obama, Kazutaka
    Hosogi, Hisahiro
    Sakai, Yoshiharu
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (12) : 3227 - 3236
  • [10] Induction Chemotherapy with S-1 Plus Cisplatin Followed by Surgery for Treatment of Gastric Cancer with Peritoneal Dissemination
    Hiroshi Okabe
    Shugo Ueda
    Kazutaka Obama
    Hisahiro Hosogi
    Yoshiharu Sakai
    Annals of Surgical Oncology, 2009, 16 : 3227 - 3236